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THE EFFECTS OF ZINC SULFATE ON ETHYL GLUCURONIDE 
IMMUNOASSAY URINE TESTING 
 
 
SHANNA MARIE CAWLEY 
 
ABSTRACT 
Published research in the Journal of Analytical Toxicology and the American 
Society for Clinical Pathology has confirmed that the presence of Zinc Sulfate in 
adulterated urine samples can influence the testing results using EMIT and ELISA 
immunoassay testing when testing for Cannabinoids (THC), Cocaine (Benzoylecgonine), 
Methamphetamines, Opiates (Morphine, Methadone, and Propoxyphene), Phencyclidine 
(PCP), and Ethanol (Alcohol Dehydrogenase).  This research included adding Zinc 
Sulfate directly to urine samples. 
In 2006, the Substance Abuse and Mental Health Service Administration 
(SAMHSA) released an advisory that the use of Ethyl glucuronide (EtG) as a new 
biomarker as an indicator for the past-use of alcohol was promising and warranted more 
research.  Ethyl glucuronide is a direct metabolite of the biotransformation of ethanol in 
the human body.  This compound is excreted in urine and can be used as a specific 
biomarker for the ingestion of alcohol.  Because EtG is only produced when ethanol is 
metabolized, there are no false positives due to fermentation and a much longer detection 
window exists for its detection.  Scientific literature states that EtG can be present in 
urine long after ethanol has been eliminated. Testing for EtG is commonly referred to as 
vi 
the “80 hour test” for the ability of EtG to be measured up to 80 hours after consuming 
alcohol. 
It was hypothesized that if the presence of Zinc Sulfate added to urine falsely 
reduced urine alcohol level when measuring for Alcohol Dehydrogenase enzyme, will the 
presence of Zinc Sulfate added to SurineTM falsely reduce the urine alcohol level when 
measuring for EtG?  Since it is very likely that EtG would still be present in the body 
after ethanol has been eliminated, samples contained either no ethanol or 5% (5g/dL) of 
ethanol.  Samples were spiked at 10mg/mL, 15mg/mL or contained 0mg/mL of Zinc 
Sulfate. Additionally, duration testing was conducted to see if there was any observed 
differences between testing the samples fresh and then after a one week duration in a 
refrigerator and brought to room temperature prior to testing.  Two different 
immunoassay EtG tests were used to perform the analysis.  It was concluded that Zinc 
Sulfate directly added to the sample affected one of the immunoassay test  
regardless of whether EtG or ethanol were present, by fading the Test and Control 
regions.  Additionally, it is concluded that SurineTM samples containing Zinc Sulfate 
could easily be distinguished from samples free of Zinc Sulfate because of the presence 
of a white cloudy precipitate.   
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1. INTRODUCTION 
1.1 Alcohol and the Human Body 
Determining the presence of alcohol in a biological fluid is the most common 
requested service from forensic scientists and toxicology laboratories worldwide.1 
According to the Center for Disease Control, within the year 2010, alcohol misuse cost the 
Unites States approximately 249 billion dollars.2  In 2013, it was found that 86.8% of 
people over the age of 18 drink alcohol3 and 88,000 people die annually due to alcohol 
related causes4.  The National Council on Alcoholism and Drug Dependence, INC reported 
that 40% of all violent crimes occurring in the United States, which accounts for 
approximately three million crimes, occurred while the offender was under the influence 
of alcohol.5   
The alcohol found in an alcoholic beverage, can be more specifically referred to as 
ethyl alcohol or ethanol.6Ethanol is produced by fermentation, a process where enzymes in 
yeast break down sugars or starches to form ethanol and carbon dioxide.7 The ethanol 
produced is a clear liquid completely miscible in water.1 There are several forms of 
alcoholic beverages which contain different ethanol concentrations.  Wines, fermented 
from grapes, range in alcohol content 12-14%.  Starches are fermented to produce beer at 
4-5% alcohol.  Distilled liquors, such as fermented molasses to form rum, or fermented 
potatoes to form vodka, have alcohol contents around 50%. 6 
There are three processes associated with alcohol in the body: Absorption, 
Distribution, and Elimination.  Alcohol is eliminated by the body by either being 
metabolized or excreted.6 Ethanol is at physiological pH and unionized therefore is can 
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passively and easily diffuses across cell membranes to be distributed throughout the body.1  
Once ingested, ethanol will immediately start to be absorbed through the linings of the 
mouth.  It will pass through the esophagus, stomach, and then small intestine.  
Approximately, 5% of the alcohol is absorbed straight from the mouth, 25% through 
stomach lining and about 65% from small intestine.6   Since the small intestine has a greater 
surface area, it will be more efficient in absorbing the ethanol when compared to the 
absorption within the stomach linings.1    
There are several factors that contribute to the rate of absorption.  These include, 
the quantity and concentration of alcohol consumed, the duration of exposure to ethanol, 
and whether food has been ingested.8 If food had been ingested, the pyloric sphincter, 
which controls the movement of stomach contents into the duodenum of the small intestine, 
would be closed and therefore the alcohol would remain in the stomach for a longer period 
of time.  If no food had been ingested, the pyloric sphincter would quickly allow the alcohol 
to pass into the small intestine, which has a greater absorption rate.1 See Figure 1 below 
for a diagram of the absorption of ethanol.  Additionally, high concentrations of alcohol 
could irritate the linings of the upper gastrointestinal tract of the body, specifically the 
stomach.  This could affect absorption of the ethanol by preventing diffusion through the 
cell membranes.6 
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Figure 1. Illustration of the absorption of ethanol from the stomach and duodenum and the effects of 
rapid or delayed gastric emptying.1  Permission from Dr. A.W. Jones to use this copyrighted diagram. 
 
Once absorbed, the alcohol is quickly distributed throughout the body by the 
circulatory system.  Just as it is easy to pass cell membranes, ethanol can easily pass 
through tissues of the body.   Organs and tissues are comprised of mostly water and are in 
constant equilibrium to blood.  Therefore, when ethanol is present in the blood, it too can 
reach equilibrium quickly throughout tissues of the body.1  Once absorbed through the 
small intestine, the alcohol is carried to the liver via the portal vein.  The portal vein, is the 
main blood vessel that drains deoxygenated blood from the gastrointestinal tract to the 
liver.  Therefore, portal blood contains the highest concentration of alcohol.1  From there, 
the ethanol is carried through the inferior vena cava to the heart and lungs where the 
oxygenated blood is carried to the brain and body tissues.  It is in the brain that ethanol has 
the most effect.  Alcohol is classified as a central nervous system depressant.1 It is within 
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the brain chemistry where users of alcohol experience loss of inhibitions, prolonged 
reaction time, loss of motor coordination, lack of good judgment, and incoherent speech, 
and euphoria.1 In large doses, alcohol can lead to unconsciousness and death.9 
After alcohol is absorbed and distributed throughout the body, it is eliminated.  
Alcohol is eliminated by two mechanisms, metabolism and excretion.6 Metabolism by the 
liver is the main mechanism of elimination and accounts for approximately 92-95% of the 
removal of alcohol, which is performed by the liver.10  The liver metabolizes ethanol via 
both oxidative and non-oxidative pathways.  Of these two pathways, the major elimination 
of ethanol is the oxidation of ethanol by alcohol dehydrogenase (ADH) and aldehyde 
dehydrogenase (ALDH).   First, ADH oxidizes, or converts, ethanol to acetaldehyde.   
Subsequently, ALDH will then oxidize acetaldehyde to acetate.11 A small percentage, 
approximately 0.1%, of alcohol metabolism is performed by non-oxidative pathways.1  For 
example, ethanol will conjugate with glucuronic acid to form ethyl glucuronide (EtG) by 
way of the Uridine 5’ diphospho (UDP)-glucuronosyltransferase family of enzymes. 12 The 
remaining 5-7% of alcohol is excreted, unchanged, in the same manner that water is 
removed from the body.  This includes breath, urine, perspiration, and saliva.13   
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Figure 2. Scheme showing paths of ethanol metabolism and excretion.1 
 
1.1.1 Testing for Alcohol 
In 1986, President Ronald Reagan signed Executive Order 12564 which advocated 
for drug and alcohol free workplaces.14  Under this Executive Order, employers were 
legally allowed to establish drug testing programs.  The goal was to be able to have more 
reliable and productive workplaces.14  Alcohol is the only drug that state and federal 
governments have established levels of intoxication.15 
Due to the nature that ethanol is miscible in water and can reach equilibrium 
throughout the body, testing for alcohol is performed on a number of matrices.  These 
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matrices include breath, blood, urine, saliva, as well as vitreous and various tissues, such 
as muscle, brain, heart, liver, lung and spleen in post mortem cases.1  However, for forensic 
toxicology, blood is the most important biological fluid for analyzing ethanol.16 The Blood 
Alcohol Curve, BAC, is a graphical representation that looks at the rate of absorption 
versus the rate of elimination. It is from this curve that the blood alcohol concentration, 
can be derived from.   All laws regarding alcohol is based on the blood alcohol level of an 
individual.  For instance, it is illegal to operate a motor vehicle if the BAC is 0.08g/dL, 
0.08% or higher.6   
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Table 1.  Stages of Alcoholic Intoxication 1  
Blood Alcohol 
Concentration, 
BAC 
(grams/100mL) 
Stages  Clinical Signs and Symptoms 
0.01-0.05 Subclinical  No obvious effects 
0.03-0.12 Euphoria  Mild euphoria,  sociability 
 Increased self-confidence, decreased inhibitions 
 Some sensory motor impairment 
 Diminutions of attention, judgment, and control 
Note: 0.08 is the BAC legal limit for driving motor vehicle 
0.09-0.25 Excitement  Emotional instability. Loss of judgement 
 Impairment of memory, perception, balance 
 Drowsiness 
 Sensory-motor incoordination 
0.18-0.3 Confusion  Disorientation, mental confusion, dizziness 
 Exaggerated emotions (i.e., fear, rage) 
 Vision disturbances 
 Staggered gait, slurred speech 
 Lethargy  
0.25-0.4 Stupor  Approaching loss of motor functions 
 Decreased response to stimuli 
 Inability to stand/walk 
 Vomiting, incontinence of urine and feces 
 Impaired consciousness, sleep 
0.35-0.5 Coma  Coma, anesthesia 
 Depressed reflexes 
 Subnormal temperature 
 Impairment of circulation and respiration 
 Possible death 
0.45+ Death  Death from respiratory arrest 
 
 
Formulas have been derived that can determine the amount of alcohol within other 
matrices, using the blood alcohol concentration.17  These formulas are referred to as blood 
alcohol distribution ratios.  Urine, for example, represents 1.3.17 The U.S. Department of 
Transportation authorized Title 49 Code of Federal Regulations (CFR) Part 40 which 
outlines the procedures for federal regulated workplace drug and alcohol testing.18  
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Currently, the federal government has approved only the testing of breath or saliva in the 
workplace for testing for the presence of ethanol.18 The testing of blood and vitreous is 
often conducted in post mortem cases.1 Generally, urine has been considered a poor matrix 
choice when looking for the presence of alcohol and will be discussed further in the next 
section.   
When testing for ethanol within any matrix, a preliminary or screening test would 
first be conducted.1 In the case of breath or saliva testing, this preliminary test is conducted 
by using a federally approved alcohol screening device.18 Such a device would be 
determining the presence of ethanol.  If the screening test was positive, then a confirmatory 
test would be performed.  Since ethanol is quickly eliminated from the body, the alcohol 
testing would not indicate prior alcohol use, just that the individual had ingested alcohol 
within a short time frame of the test being conducted. 
 
1.1.2 Urine Alcohol Testing 
Urine was the first body fluid used for determination of ethanol in clinical and 
forensic testing, probably due to the large volume available without invasion of the body.19   
However, urine is considered a poor matrix to test for the presence of ethanol and is not an 
approved matrix for federal workplace testing.1  There are several known limitations in 
testing urine.  There is a small window to detect the presence of ethanol due to the fact that 
it is quickly metabolized and eliminated, approximately 0.1 gram per kilogram per hour.20  
The concentration of ethanol within urine is dependent on the time of voiding.21  Therefore, 
an individual who has not voided frequently would appear to have a higher concentration 
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of ethanol than an individual who had voided recently.   Additionally, if there was alcohol 
free urine present prior to a drinking episode, that could dilute the concentration of ethanol 
in the freshly produced urine.22  Ethanol is a diuretic, meaning it increases the urge to 
urinate more frequently.1. Additionally, there is potential for false positives when ethanol 
is produced by the fermentation of glucose by certain organisms.  For instance, an 
individual with an infection or diabetes may have excessive glucose and/or microorganisms 
that could turn that excess glucose into ethanol by fermentation1 
There is a need to know if an individual has ingested alcohol.  Even though the use 
of urine alcohol testing is not approved in federal workplace testing, there are many 
agencies and practices that do test urine in order to determine if an individual used alcohol.  
These agencies would include small private workplace testing, drug courts, medical 
professionals, rehabilitation facilities, and sober living facilities that may house those who 
have graduated from alcohol rehabilitation and must still remain abstinent from alcohol. 
Extensive research is being performed to identify metabolites or another analyte that would 
be conclusive to alcohol use.23 Looking for elevated levels of alcohol dehydrogenase in 
urine would indicate alcohol has been recently metabolized in the body.23  Alcohol 
biomarkers are physiological indicators of alcohol exposure or ingestion and can either be 
classified as direct or indirect.23  Indirect biomarkers are classified as such because they are 
detected by the toxic effects that alcohol would have on an organ or body chemistry.23 
Therefore, an indirect biomarker would not be a byproduct of ethanol metabolism, but 
rather a particular analyte that it present due to alcohol use.  An example would be gamma 
glutamyl transferase (GGT) which when found in high quantities, reflects liver damage and 
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therefore could be used to screen a user who consumed regular alcohol over a period of 
time.  Direct biomarkers would be analytes of alcohol metabolism.  An example of a direct 
biomarker would be ethyl glucuronide, which is described in detail below.   
 
1.2 Ethyl Glucuronide (EtG) 
 As described in previously in Section 1.1, there are minor non-oxidative pathways 
to metabolize alcohol in the liver.   Ethyl glucuronide is the conjugation of ethanol with 
uridine 5’-diphospho-glucuronic acid (UDPGA).  It is catalyzed by the endoplasmic 
reticulum via the membrane-bound mitochondrial UDP-glucuronyl transferase enzymes 
(UGTs)24.   EtG has been found in urine, blood, salvia, and hair.21  It is found that EtG 
can be detected in urine for +/- 80 hours and detected in blood +/- 18 hours.20 The 
Substance Abuse and Mental Health Service Administration (SAMHSA) published an 
Advisory in 2012 stating that ethyl glucuronide is a new and promising alcohol 
biomarker that warranted further research.23 Prior to 1995, the only way to isolate EtG 
was from urine specimens.  In 1995, Schmitt and his associates developed a method to 
synthesize and quantify EtG using Gas Chromatography-Mass Spectroscopy.25  In 2010, a 
second method was validated that allowed for a fast, simple, and sensitive procedure 
according to forensic guidelines which utilized High Performance Liquid 
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Chromatography.26 The development of these methods to validate EtG allowed 
researchers to further investigate all the uses and applications for EtG testing.27, 28 
Researchers have concluded that ethyl glucuronide can be used as a tool for 
alcohol testing and treatment as it is specific, sensitive, and stable.28  
EtG is specific as it is a direct metabolite from the alcohol metabolism process 
and will only be present in urine after exposure to ethanol.29  Therefore, unlike ethanol 
testing in urine, there is no concern that the analyte could be produced in the presence of 
sugars, which is a concern for ethanol testing in urine.29  It’s specificity makes it relevant 
in post mortem testing for cases involving decomposed and putrefied bodies.30  In these 
types of cases, there is a risk that a positive blood alcohol concentration may have been 
produced after death due to microbial processes.  However, an elevated EtG finding 
would suggest that ethanol had been metabolized in order for EtG to be present.30 
EtG testing is sensitive as only approximately 0.02-0.04% of the ethanol dose 
ingested is recovered in the urine as EtG.31, 32  EtG is found in urine even after the ethanol 
itself has been eliminated from the body. Research has shown that EtG can remain in the 
body ten times longer than ethanol.33  It has been commonly referred to as the “80 hour 
test.34”  EtG has been detected in urine up to 80 hours after a drinking episode.  However, 
this is only true for very large drinking episodes.34  Borucki demonstrated that the 
detection of EtG resulted in 100% sensitivity at approximately 40 hours with detection 
consistency decreasing after that time.34  With such a sensitive analyte the concern of a 
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heavily diluted versus highly concentrated urine sample is drecreased.  EtG can still be 
detected even from highly diluted samples.26 
Ethyl glucuronide is a stable analyte.  It was found that it remained stable in urine 
for four days at room temperature.35 Stability duration over a one week time frame and 
freeze-thaw tests over a six month time frame were conducted and it was concluded that 
the calculated decrease never exceeded 15%.26 
EtG testing is more reliable than other standard alcohol tests.  In Germany, Penal 
Code Section 64 is titled, “Custodial addiction treatment order” and states that if a person 
addicted to drugs or alcohol commits an unlawful act while intoxicated or as a result of 
their addiction, the court may provide the option for treatment instead of incarceration36.   
These unlawful acts could include murder or rape, and the individual would have no legal 
responsibility.  The treatment of these individuals is unique because it provides a well-
controlled monitoring opportunity of these addicted patients.37  In recent years, several 
studies have looked at alcohol dependent individuals in Germany.38,39  In 2009, a group 
of researchers, led by Klaus Junghanns, investigated EtG testing with a group of 107 
individuals who were released from an alcohol detoxification facility.38 They were to 
return for follow up care with the medical staff at three, six, and 12 weeks post discharge.  
Standard practice of alcohol abstinence would be to monitor with Breathalyzer testing 
and personal interviews.  The 107 test individuals also agreed to urine EtG testing.  
Junghanns and his associated found that after the three, six, and 12 week appointments, 
12%, 19%, and 28%, respectively, of the individuals had a positive EtG test when they 
demonstrated a negative breathalyzer test and had no findings at their interview.38  A 
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second similar study led by T. Wetterling in 2014, looked at 297 alcohol dependent 
patients in German psychiatric hospitals that were part of long term alcohol dependence 
treatment.39  After being allowed a weekend at home, they were evaluated with the 
standard Breathalyzer and interview.  Additionally, the participants agreed to urine EtG 
testing.  It was concluded that 38% of participants tested positive for EtG.  Breathalyzer 
testing was positive 4.4% of the time and 5.7% of individuals admitted relapse in the 
interviews.  93% of the relapses were detected by only ethyl glucuronide.39 
 These studies demonstrated that EtG has advantages as a screening tool for 
alcohol use, however, there are two main disadvantages.  The first is concerning bacterial 
contamination.  Escherichia coli, is the most prevalent pathogen to cause urinary tract 
infections40 and has been found to contain a high level of -glucuronidase, which cleaves 
glucuronide.41 This knowledge prompted researchers to see the effects of E. coli on EtG 
within urine.42 Hospital samples were supplemented with EtG and were stored in 
different conditions.  It was concluded that EtG is affected by the presence of E. coli, as 
would be seen in an individual who had a urinary tract infection.42  A second 
disadvantage is with unintentional or secondary exposure.27  Since alcohol is found in 
many products, secondary exposure is possible with food products, mouthwash, hand 
sanitizers, cough syrup, and perfumes and could result in finding EtG in an individual’s 
urine.  Therefore, there is concern that EtG testing may be too sensitive.  It is necessary to 
establish cut off levels to ensure that the level seen in the urine would be from drinking 
an alcohol beverage and not from being exposed to alcohol through common daily 
products.  Many researchers are currently investigating the results of secondary exposure 
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for EtG urine testing.  Based on the research conducted, the scientific community 
established a 500 ng/mL threshold to eliminate secondary exposure.27 
A common household item is mouthwash, therefore there has been several studies 
looking at EtG levels after the use of mouthwash.43,44  One study looked at two different 
conditions in which all samples from both conditions were analyzed using Liquid 
Chromatography- Mass Spectrometry with a limit of detection and quantification of 
50ng/mL.43    The first condition gave volunteers a 4-oz. bottle of mouthwash that had 
12.5% ethanol.  They were instructed to gargle for 15 minutes and repeat till the 4-oz 
bottle was empty.  They had to finish the task within 15 minutes.  Their urine was then 
collected for a 24 hour period and analyzed.  78% of the samples resulted in EtG levels 
less than 100ng/mL.  22% of the samples resulted in EtG levels less than 300 ng/mL.  
The second condition, instructed the volunteers to gargle three times a day for 5 days.  
The first morning void was collected by each volunteer and analyzed.  Only 29% of the 
samples resulted in an EtG reading greater than the limit of detection at 50 ng/mL.  Out 
of those samples, none of them exceeded 120 ng/mL.43 
 A second mouthwash study looked at results of EtG in urine after using a high 
content mouthwash, at 29.6% ethanol.44 Volunteers gargled four times a day for three and 
a quarter days.  The first morning void was collected each day as well as 2, 4, and 6 hours 
after first gargle.  The analysis was performed by both an immunoassay EtG technique, 
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DRITM EtG, Microgenics, as well as a Liquid Chromatography- Tandem Mass 
Spectrometry, LC-MS-MS method.  The highest EtG level detected was 173ng/mL.44 
 Additional studies have looked at EtG levels after consuming food products to 
have known alcohol contents.45  A peak reading of EtG at 512ng/mL was detected after 
consuming two nonalcoholic beers. EtG was detected in urine at 200 ng/mL after 
consuming sauerkraut and a level of 120 ng/mL after consuming ripe bananas.45 
 Debatably, the most controversial secondary exposure of ethanol would be from 
hand sanitizers due to daily exposure within some professions.  One study found that 
using hand sanitizer twenty times a day within as twelve hour period never detected EtG 
in urine greater than 120 ng/mL.46 Another study had volunteers use Germ-XTM either 
every 60 minutes, 30 minutes, or 15 minutes throughout one workday.  Urine samples 
were collected every four hours and analyzed with Liquid Chromatography-Tandem 
Mass Spectrometry (LC-MS-MS).  The highest level of EtG detected was 62 ng/mL.47 A 
controversial report was printed in the The Wall Street Journal in which a nurse had 
failed a urine EtG test with a concentration of 770ng/mL.48  She often used hand sanitizer 
with her line of work and was adamant that she had not consumed alcohol.48 Reisfield 
and associates conducted a research study to attempt to determine the highest 
concentrations of EtG using hand sanitizer.49 Volunteers used PurellTM every five minutes 
for ten hours over three days.  The mean EtG concentration of all the samples was 
278ng/mL.  However the 95th – 99th percentiles were readings between 1037-1645 
ng/mL.  The highest level reached was 2001 ng/mL.49  Currently the SAMHSA 
recommends those who perform EtG testing are to forewarn individuals of possible 
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secondary exposures and to avoid their use.23  The conclusion around cutoff levels can be 
found in Table 2 below. 
 
Table 2. Current SAMHSA Guidelines of EtG Cut-off Levels23 
Result Level Description 
High Positive >1,000 
ng/ml 
Heavy drinking on the same day or 
previous day 
 Light drinking the same day. 
Low Positive 500-
1,000ng/ml 
Previous heavy drinking (1-3 days) 
Recent light drinking (past 24 hours) 
Very Low Positive 100-
500ng/ml 
Previous heavy drinking (1-3 days) 
Previous light drinking (12-36 hours) 
Recent extraneous exposure 
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Table 3.  Timeline and Highlights of Ethyl Glucuronide Research.   
 
 
 
 
  
Year Conclusion 
1901 First described the non-oxidative pathway of alcohol elimination 
via a conjugate with glucuronic acid.51 
1952-
1973 
Ethyl glucuronide was determined in human urine.52,53 
1995 Ethyl glucuronide can be synthesized, quantified, and analyzed by 
GC/MS. This allows for a simple and reliable method for further 
analysis and research of EtG.25 
 
2002 EtG stable at room temperature in urine for 4 days.35 
2005 Sensitivity testing found 80 hour test only applies to very large 
drinking episodes and is a misleading name of test.  EtG was 100% 
sensitive for about 40 hours after ingestion.34 
2005 It is discovered that EtG can be produced or degraded in urine 
sample containing particular bacterial contamination.42 
2008 Evaluation of new immunoassay for urinary ethyl glucuronide 
testing showed to be promising and could make testing more 
practical for clinical and forensic settings.50 
2008 Kinetics of EtG studied in a controlled drinking experiment. 
Determined EtG remains in the body 10 times longer than ethanol 
and therefore can be detected long after ethanol can be measured.33 
2009 EtG shows to be more reliable than standard breathalyzer 
testing.38,39 
2010 A specific, sensitive, and robust method for quantitation of EtG and 
EtS in human urine using LC–MS–MS has been developed and 
fully validated. Validation data for selectivity, linearity precision 
and accuracy, recovery as well as for processed sample and 
freeze/thaw stability was performed.26 
2012 SAMHSA concludes that EtG is a promising new alcohol 
biomarker that should be further studied.23 
2014 Further EtG testing in an alcohol treatment program concluded that 
EtG is more reliable in detecting alcohol use than current 
procedures.39 
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1.3 Zinc Sulfate 
Zinc Sulfate, ZnSO4, is a compound that has been used throughout history to treat 
a variety of aliments including convulsions, urethral discharge, acne vularis, and 
diarrhea.54  It can be bought as an over the counter supplement to treat individuals 
experiencing low zinc levels.  Zinc is an essential mineral important for gene expression 
by binding to cysteine and histidine to form looping structures known as zinc fingers. 
Zinc is found in metalloenzymes, which is a group of enzymes that have a metal ion 
within the protein.  Some common metalloenzymes include acid phosphatase, alcohol 
dehydrogenase, as well as DNA and RNA polymerases.55  The average daily intake of 
zinc is between 9-12 mg per day and can be met by eating foods high in zinc such as 
leafy vegetables, meat, fish, and poultry. 54 
Once consumed, zinc is mainly absorbed in the jejunum.54  Cells lining the lumen 
of the jejunum contain metallothionein, a protein that binds heavy metals. 
Metallothioneins have a strong affinity for zinc and copper, in which they are the 
regulating mechanism for the body. When excessive amounts of zinc are absorbed, an 
increase in mettalothionein occurs.  These additional metallothioneins will bind to copper 
resulting in an excessive elimination of copper.  Therefore there is a direct correlation 
between elevated zinc levels and copper deficiency.  The metallothionein and zinc 
complex is then passed primarily through feces.54 
In recent years it was discovered that zinc was an adulterant to invalidate urine 
immunoassay drug tests.56, 57, 58 Online forums detail methods to try to cheat drug test by 
either adulterating the sample with Zinc Sulfate or consuming Zinc supplements.  When 
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consuming supplements, the most popular instruction was to consume 250mg of Zinc 
Sulfate the night before the test and another 250 mg of Zinc Sulfate the morning of the 
test.59 Online drug forums base their beliefs that Zinc Sulfate adulterates the test because 
the zinc will bind to the drug of interest and be passed through the feces and not the 
urine.60 This would be based on the metallothionein and zinc complex that is discussed 
previously in this section.   
Initial research conducted in 2011 by Venkatratnam and Lents, concluded that 
zinc sulfate was effective in interfering with the detection of cocaine, methamphetamine, 
and tetrahydrocannabinol (THC) when using the National Institute of Drug Abuse 
(NIDA) 5 panel Enzyme linked immunosorbent assay test, otherwise known as an ELISA 
test.56.  ELISA testing separates specific antigens by capturing them with an antibody.61  
Two experiments were performed as part of that study.  The first introduced varying 
concentrations of zinc sulfate to spiked urine samples containing the drug of interest.  It 
was concluded that zinc sulfate levels between 10-15 mg/mL successfully resulted in a 
negative test result within a sample that was known to be positive.  The second part of the 
experiment used human volunteers that provided regular urine samples while using 
marijuana and consuming zinc supplements.  The volunteers were instructed to take (4) 
50mg tablets of zinc sulfate.  It was concluded that consuming zinc sulfate supplements 
after light marijuana use interfered with the sample for a 12-18 hour period.  
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Venkatratnam and Lents hypothesized that the “zinc ion increased the binding of the drug 
conjugate to the enzyme within the drug test itself.”58 
A second follow up study of the effects of Zinc was conducted in 2013.57  The 
goal of this research was to determine whether Enzyme multiplied immunoassay 
techniques, otherwise known as EMIT-based testing was subject to interference described 
previously for the ELISA-based testing and to investigate the expected concentrations of 
zinc in the urine of patients after self-administration of zinc in the manner consistent with 
reported attempts to circumvent positive drug screening results. EMIT Immunoassay 
testing takes a sample with analyte of interest and adds a fixed quantity of enzyme bound 
analyte and anti-analyte antibodies.61  Absorbance measurements are taken at intervals to 
determine the speed of enzyme reactions.  The more free analyte in the samples, the 
faster the enzyme activity61 The research concluded that the addition of zinc sulfate 
directly to urine did produce false negative results using the EMIT-based testing.  These 
researchers however, did not find that consuming zinc supplements could interfere with a 
drug test as the level of zinc needed in the urine would need to be at a minimum, 4,200 
times higher than the standard zinc urine level. 57 
A third area of research conducted in 2013, again confirmed that zinc sulfate in 
varying concentration achieved false results when using EMIT-based testing for the 
detection of barbiturates, benzodiazepines, opiates, benzoylecgonine, marijuana 
metabolite, methadone, phencyclidine, and propoxyphene.58  However, these researchers 
did not observe any effect on amphetamines. Additionally, these researchers also looked 
at the effects of zinc sulfate on urine alcohol tests.  It was stated that urine alcohol testing 
21 
is frequently ordered test within the researcher’s laboratory.  The researchers chose to use 
an alcohol enzymatic assay test using alcohol dehydrogenase.  It was concluded that zinc 
sulfate falsely reduced the measured urine alcohol level in urine by an average of 39%.  
At the time of this research, it was noted that to the knowledge of the researchers, 
“negative interference of zinc sulfate in urine alcohol testing had not been reported.58” 
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Table 4.  Summary of Zinc Sulfate Research on Adulterating Drug Tests  
Ref Tested Drugs Analysis Modes of 
Zinc 
Conclusions 
56  Cocaine 
(Benzoylecgonine) 
 Methamphetamine 
 Cannabis (THC) 
ELISA assay 
 
UV 
Spectrometer 
Zinc sulfate 
added to 
urine samples 
spiked with 
drugs. 
1. Zinc sulfate in levels 
between 10-15mg/mL 
resulted in false negative 
test results when added 
directly to urine 
2. Zinc supplements after 
light marijuana use 
interfered with test 
results for a 12-18 hr 
period. 
Human 
volunteers 
consumed 
200mg of 
zinc 
supplements 
57  Cocaine 
(Benzoylecgonine) 
 Methamphetamine 
 Cannabis (THC) 
 Opiate (Morphine) 
EMIT assay 
Inductively 
coupled 
plasma-mass 
spectrometer 
 
Zinc sulfate 
added to 
urine samples 
spiked with 
drugs. 
1. Zinc sulfate levels 
between 5-10mg/mL 
resulted in false negative 
test results when added 
directly to urine. 
2. Zinc supplements did 
not interfere with urine 
levels as the required 
level of zinc present in 
urine would have to 
exceed 4,000 times the 
normal zinc range. 
Human 
volunteers 
consumed 
200mg of 
zinc 
gluconate the 
day prior and 
day of 
testing. 
58  Amphetamine 
 Barbiturates, 
 Benzodiazepines, 
 Opiates, 
 Cocaine 
(Benzoylecgonine) 
 Cannabis 
(marijuana metabolite) 
 Methadone 
 Phencyclidine 
 Propoxyphene 
 Ethanol 
EMIT assay 
with a Vista 
Analyzer. 
 
Alcohol 
dehydrogenas
e enzymatic 
assay analyzer 
Zinc sulfate 
added to 
discarded 
urine samples 
sent in for 
testing. 
 
1. Zinc sulfate levels 
between 10-15 mg/mL 
resulted in false negative 
test results when added 
directly to urine. 
2. Amphetamine samples 
were not affected by zinc 
sulfate. 
3. Zinc sulfate falsely 
lowered values with 
urine alcohol testing. 
Different 
concentration
s of zinc 
sulfate added 
to urine 
samples 
spiked with 
drugs. 
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2. MATERIALS AND METHODS 
2.1 Materials 
SurineTM Negative Urine Control was purchased from Cerilliant (Round Rock, 
Texas) to be used as the matrix for the testing.  Solid Ethyl--D-glucuronide, was 
purchased from Toronto Research Chemicals (Toronto, Canada).  One milligram was 
added to one milliliter of SurineTM to create a stock solution that was used to make a serial 
dilution in order to obtain nanogram per milliliter levels for testing.  Zinc Sulfate 
Heptahydrate was purchased from Sigma-Aldrich (St Louis, MO) and 200 Proof Ethanol 
was obtained from Fisher Scientific (Pittsburgh, PA).  Two different ethyl glucuronide 
immunoassay tests were ordered.  80 Hour Instant ETG Alcohol DipStick Tests with a 500 
ng/ml cut off level were purchased online from Drug Tests In Bulk (West Hills, California) 
and EtG Urine Alcohol Test Dip Card with a 500 ng/ml cut off were purchased online from 
TransMed Drug Testing and Laboratory Supplies (Alfaretta, Georgia). 
 
2.2 Design and Method 
To expand on the previous research on the effects of zinc sulfate on drug and 
alcohol testing, the design of this experiment was to investigate the effects of zinc sulfate 
on ethyl glucuronide alcohol testing as this preliminary screening test for alcohol has 
started to gain a more wide spread use.   
The EtG tests with a 500 ng/ml cut off was used as it is currently the approved 
standard level that is accepted to eliminate secondary exposure.27  In order to not overlap 
target values, the second level of 700 ng/ml was chosen.  To take into consideration a 10-
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20% coefficient of variation, the experiment would use the 500 ng/ml and 700 ng/ml levels 
of EtG.  If Zinc Sulfate was shown to reduce the EtG by an average of 39%, just as was 
seen with alcohol dehydrogenase, then the urine immunoassay test would appear negative.  
Additionally, to account for a 20% coefficient of variation when factoring in the 
measurements of uncertainty, the 700 ng/mL value would still fall above the 500 ng/mL 
detection range of the immunoassay cut-off. 
Additionally, it was found from previous stability testing, that EtG never decreased 
by more than 15%.35   Therefore, samples were tested fresh and at one week.  It could be 
considered that up to a 15% loss of EtG in the sample may occur.  The one week samples 
were stored in the refrigerator and brought to room temperature prior to testing.   
Table 5.  Visual Representation of Variables in the Design of the 
Experiment.  The variables and each interval or level outline in table format. 
 
Variables Intervals 
Immunoassay 
Drugs In Bulk 
TransMed Drug Testing 
and Laboratory Supplies 
Duration 
Fresh 1 week 
Ethanol 
0 % (0.0 mg/dl) 0.05% (50mg/dl) 
Zinc Sulfate 
0mg/ml 10 mg/ml 15 mg/ml 
EtG 
0 ng/ml 500ng/ml 700 ng/ml 
 
Glass vials were used to prepare each sample.  To prepare the samples that 
contained the EtG analyte, one milligram of the EtG was measured and added to milliliter 
of SurineTM.  It was then made into serial dilutions to obtain the target levels of EtG in the 
SurineTM.  Each round of testing was created from a new 1mg/ml stock solution.  See Table 
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A and Table B within APPENDIX A of this document for details of the serial dilutions.   
The zinc sulfate, which was a white crystal, was first crushed within filter paper to decrease 
the particle size.  It was then measured using a Denver Instrument Pinnacle Balance 
(Bohemia, NY) and added directly to each glass vial. This resulted in 12 glass vials, 
referred to as Vials 1-12, each testing a different scenario.  Vials 13 and 16 were considered 
Control Vials as they contained no EtG or Zinc Sulfate.  Vials 14, 15, 17, and 18 were 
considered the Negative Vials as they contained Zinc Sulfate, but did not contain the EtG, 
which was the analyte being tested.  Both the Control and Negative vials were used to 
prove that the EtG dipstick screening tests were working properly. See Table C within 
APPENDIX A of this document for details of the contents of each of the vials.  All solutions 
were made using a pipette and each vial was vortexed for approximately 30 seconds.  A 
spot well plate was used to execute the tests.  For the Drug Test In Bulk tests, 120 
microliters from each vial was pipetted into separate wells.  For the TransMed vials, 350 
microliters from each vial was pipetted into separate wells as the dip card tips were larger 
and a therefore needed a larger volume to fully submerged the dip stick.  Each vial was 
tested three times for reproducibility. 
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3. RESULTS  
3.1 Results and Observations 
 Appendix A:Table D provides a visual representation of the results of the EtG 
immunoassay cards from Drug Tests In Bulk.  The results from vials 1, 2, 3, 4, 5, and 6 
were found to be negative for EtG.  After waiting the 5-minute recommended reading 
time, a faint second line developed, indicating a negative test. Even the samples that had 
no Zinc Sulfate present had the same observations.  Vials 7, 8, 9, 10, 11, and 12 
consistently tested positive for EtG for all 3 of the reproducibility tests.  The control 
vials, Vials 13, 14, 15, 16, 17, and 18 consistently tested negative for EtG for all three of 
the reproducibility tests.  There were no observed differences between samples that 
contained no level of ethanol or had ethanol present. There were no observed differences 
between the samples tested fresh versus the sample tested one week later.   
 
Appendix A:Table E provides a visual representation of the results of the EtG 
immunoassay cards from TransMed Drug Testing and Laboratory Supplies.  Vials 1, 4, 7, 
and 10 were negative.  After waiting the 5-minute recommended reading time, a faint 
second line developed, indicating a negative test for Vials 2, 3, 5, 6, 8, 9, 11, 12, 14, 15, 
17, 18.  Vials 13, 14, 16, and 17 consistently tested negative for EtG for all three of the 
reproducibility tests.  There was no observed differences between samples that contained 
no level of ethanol or had ethanol present. There were no observed differences between the 
samples tested fresh versus the sample tested one week later.   
The samples screened using the Drugs Test In Bulk 500 ng/mL detection cut-off 
immunoassay cards were analyzed first.  Upon completion of those tests, results were 
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documented and the samples were discarded. The results showed that samples containing 
500ng/mL of EtG were negative.  See Figure 3. The samples containing 700ng/mL of EtG 
yielded positive test results.  The presence of ethanol or Zinc Sulfate did not appear to have 
an effect on results, as neither did the samples tested after one week of storage.  Fresh 
samples were prepared to be tested using the TransMed immunoassay cards with a cut-off 
detection limit of 500ng/mL.  All samples containing EtG, at both the 500ng/mL and 700 
ng/mL levels, were negative.  The presence of ethanol and the one-week duration did not 
appear to have an effect on any of these samples.  However, there was a very clear and 
dramatic observation seen when Zinc Sulfate was present in the samples.  Samples 
containing no Zinc Sulfate presented with clear lines.  Samples containing 10mg/mL of 
Zinc Sulfate tested with much fainter lines when compared to the samples containing no 
Zinc Sulfate.  Samples containing 15mg/mL of Zinc Sulfate completely invalidated the test 
as in all lines, even the control lines, were so faint they were undetectable (Figure 4). The 
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effects of Zinc Sulfate do not appear to be specific to just EtG immunoassay cards as the 
Control Vials were also affected (Figure 5).  
 
 
 
 
Figure 3. 500 ng/mL EtG compared to Negative control using Drug Test in Bulk immunoassay test.  
Negative Control (A) Negative 500 ng/mL (B)  
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Figure 4. The effects of Zinc Sulfate on samples prepared as 700 ng/mL of EtG and 5% ethanol using 
the TransMed immunoassay test.  Fresh sample with no Zinc Sulfate present.  Note the faint second line 
indicating a negative result even though ethyl glucuronide was present. (A) Fresh sample containing 
10mg/mL of Zinc Sulfate. (B) Fresh sample containing 15 mg/mL of Zinc Sulfate.  
 
 
 
 
 
Figure 5. The effects of Zinc Sulfate on Control samples containing no Ethyl Glucuronide using the 
TransMed immunoassay test.  Fresh sample containing only SurineTM and ethanol. (A) Fresh sample 
containing SurineTM, ethanol, and 10mg/mL of Zinc Sulfate. (B) Fresh sample containing SurineTM ,ethanol, 
and 15 mg/mL of Zinc Sulfate.  
A B C 
A B C 
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 After observing the results of the testing using the TransMed immunoassay cards, 
a reevaluation of the results using the Drug Test In Bulk testing was performed.  It had 
been originally concluded that Zinc Sulfate did not have an effect on the Drug Test In 
Bulk immunoassay test.  It was noted that sometimes the Control line appeared to not be 
uniformed.  Since the Control line was still always present, and not any lighter in color, 
the appearance of a not uniformed line had been discarded.  See Figure 6 below. 
 
 
Figure 6. The effects of Zinc Sulfate on samples containing 500 ng/mL EtG using the Drug Tests In 
Bulk immunoassay test.  Fresh sample with no Zinc Sulfate present (A) Fresh sample containing 10mg/mL 
of Zinc Sulfate. (B) Fresh sample containing 15 mg/mL of Zinc Sulfate. Note the irregular control line. 
 
 
 
 
 
A B C 
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It was observed that the Zinc Sulfate crystals took approximately one minute to 
dissolve completely.  Once dissolved, there was a cloudy white appearance within the vials 
compared to viewing the vials that did not contain Zinc Sulfate (Figure 7). Additionally, 
when the vials were removed from the refrigerator after sitting for one week, white 
sediment could be seen settled at the bottom of the vial (Figure 8). The settled white 
sediment could easily be dissolved again into the solution, however, it again would display 
the cloudy white appearance as previously seen.  It was noted that even though some vials 
contained more Zinc Sulfate, visually, there was no difference in observations between the 
10 mg/mL and 15 mg/mL levels of Zinc Sulfate.   
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Figure 7. View of vials with and without the presence of Zinc Sulfate after being vortexed.  Fresh sample 
with no Zinc Sulfate present (A) Fresh sample containing 10mg/mL of Zinc Sulfate demonstrating cloudy 
white precipitate (B) 
 
 
Figure 8. View of vials with and without the presence of Zinc Sulfate after sitting for one week in 
refrigerator.  Fresh sample with no Zinc Sulfate present (A) Fresh sample containing 10mg/mL of Zinc 
Sulfate demonstrating white sediment at bottom of vial (B) 
A B 
A B 
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4. DISCUSSION 
4.1 Immunoassay Tests and the Effect of Zinc Sulfate 
Enzyme Immunoassay, or EIA tests, are common in forensic laboratories for 
preliminary testing.  The EtG immunoassay tests are based on the principle of competitive 
binding in a lateral flow system.61,62 If EtG is present in the urine specimen above the 
designated cut-off, the EtG will compete against the respective drug conjugate for binding 
sites on their specific antibody that is located immobilized within the test region of the test. 
Once the dipstick is placed within the urine samples, the sample migrates up the dipstick 
card by capillary action.   If EtG is present below the 500ng/mL cut-off concentration, the 
EtG will not saturate the binding sites of the specific antibody which is immobilized within 
the test region with corresponding drug-protein conjugates.  For the TransMed and Drug 
Test In Bulk tests, the specific antibody is a mouse monoclonal antibody.63 Therefore, in 
the absence of EtG, the mouse monoclonal antibody will react with the drug-protein 
conjugate and a visible colored line will show up in the test region, indicating a negative 
result.  If EtG is present above the cut-off concentration of 500 ng/mL, all of the binding 
sites on the monoclonal mouse antibodies will be saturated, so a colored line will not be 
able to form since the antibody will not react.  Regardless of the levels of EtG in a sample, 
the control region has a parallel immunoassay test against the goat antibody present in the 
control region63 to demonstrate that the test is working appropriately.61,62 
As seen with this experiment, two different EtG drug screening tests demonstrated 
two different results. The first difference pertained to sensitivity, as the Drugs Test In Bulk 
tests resulted in the samples containing 700ng/mL of EtG as positive, while the TransMed 
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tests resulted in the samples containing 700 ng/mL of EtG as a negative. The second 
difference, occurred when the TransMed tests clearly demonstrated that Zinc Sulfate 
invalidated the test while the tests from Drug Tests In Bulk did not.  The TransMed tests 
came with a detailed package insert.  Within the provided product information it stated, 
“Each test in the Test Strip contains mouse monoclonal antibody-coupled particles and 
corresponding drug protein conjugates.  A goat antibody is employed in each control 
line.63”  The Drug Tests in Bulk did not provide a EtG specific package insert, but rather a 
general insert that briefly describes all the drug screening tests offered through the 
company.  Within the list of screening tests, Ethyl Glucuronide 500 ng/mL cut off was 
listed. There were no details describing the reagents within the EtG specifically.  Drug 
Tests in Bulk was contacted and provided over email that the test reagents were the same 
as in the TransMed tests.  It had been previously hypothesized from the study that looked 
at Zinc levels using EMIT testing, that “the interference with zinc is likely due to an 
alteration in antibody/antigen interaction or an inhibition of enzymatic activity”.57 The 
results from this experiment would support that hypothesis as it appears the Zinc Sulfate 
did not specifically interact with the EtG, but rather all positive and negative samples, even 
the control lines were affected by the Zinc Sulfate.   
If it is to be hypothesized that the zinc is interfering with the antibody/antigen 
interaction or an inhibition of enzymatic activity, 57 then the role of Zinc in protein binding 
should be investigated.  No specific literature could be found on the effects of Zinc on 
immunoassay testing, however, research has concluded that Zinc does play a role in protein 
binding.  Some conclusions found in scientific literature include that Zinc will form stable 
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complexes with proteins, interact with protein folds, and enhances the binding of protein 
to specific receptors.64,65  Zinc may be playing a role in the binding sites on the antibodies 
preventing a colored line to form. 
 
4.2 Zinc Sulfate as an Adulterant  
Even though there is evidence that Zinc Sulfate adulterates drug and alcohol 
screening tests by being self-administered or being added directly to a sample,56,57,58 it 
appears it would not be successful to invalidate a test in an actual work place drug screening 
collection.  First, it was found that in order to have a concentration of zinc in urine to be 
able to interfere with a test, the concentration would be approximately 4,200 times higher 
than the upper end of the established zinc reference level of 15-120g/dL.57  Secondly, as 
seen in Figure 7 and Figure 8, the Zinc Sulfate added directly to the urine resulted in a 
cloudy white precipitate that would be noticed by a trained collector according to the DOT 
Urine Specimen Collection Guidelines, 49 Code of Federal Regulations (CFR) Part 40.66  
49 CFR Part 40 is the protocol to be followed by Drug Testing Programs according to the 
Unites States Department of Transporatation.66  Anyone who is acting as a collector in the 
drug testing programs must meet training requirements that include knowledge of 49 CFR 
Part 40, Qualification training, and proficiency demonstrations.  49 CFR Part 40 states that, 
“a collector must inspect the specimen for unusual color, presence of foreign objects or 
material, or other signs of tampering or adulteration”.66 Certainly, evidence of the cloudy 
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white precipitate is more pronounced when compared to a urine control, which is not used 
in drug testing programs.  However, a trained collector could see that the sample is unusual. 
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5. CONCLUSIONS 
5.1 Conclusion 
In conclusion, samples tested with the TransMed immunoassay urine test were 
affected by the presence of 10mg/mL and 15 mg/mL of Zinc Sulfate as the colored bands 
were faded.   It was not conclusive that Zinc Sulfate had an effect on invalidating the Drug 
Tests In Bulk immunoassay urine tests.  Additionally, it is concluded that SurineTM samples 
containing Zinc Sulfate could easily be distinguished from samples free of Zinc Sulfate 
because of the presence of a white cloudy precipitate.   
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6. FUTURE CONSIDERATIONS  
6.1 Future Consideration 
The conclusions from this study would warrant some future considerations and 
areas of research.  The effects of Zinc Sulfate, invalidated not just samples with EtG, but 
rather all samples, including the controls.  At this time, no research was found that involved 
the effects of Zinc, in any form, on any immunoassay test.  Since immunoassay tests are 
used to test a variety of analytes in both forensic and clinical settings, the effects of zinc on 
these tests should be further investigated.  Furthermore, it was unexpected to find that two 
EtG immunoassay urine tests had different results, even though their regents had been 
reportedly the same.  Further research could look at other EtG immunoassay urine tests to 
determine if Zinc Sulfate had an effect.  Additionally, the cloudy appearance of the Zinc 
Sulfate seen in the SurineTM may not be as apparent when in solution with human urine.  
Future considerations could also try testing solutions made from human urine and not 
synthetic urine.  
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APPENDIX A:   
Table A: Serial Dilutions for Obtaining 500ng/mL Ethyl Glucuronide. 
Single 
Analyte 
Initial Working Stock 
Solution #1 
(1 µg/mL) 
Total Volume= 10mL 
Working Stock 
Solutions #2 
(500 ng/mL) 
0% Ethanol Level 
Total Volume= 10mL 
Final Result 
Ethyl 
Glucuronide 
1 mg of 
EtG in 1 
mL or 
SurineTM 
 
10 µL of 1 mg/mL in 
9990 µL of SurineTM 
5 mL of 1 µg/mL 
Working Stock Sol. 
#1 in 5 mL of 
SurineTM 
3 mL of 500 
ng/mL Working 
Solution #2 was 
pipetted into 3 
glass vials, 
labeled Vials 1-
3.* 
 
* Vials 1, 2, and 3 contain either 0 mg/mL of Zinc Sulfate, 10 mg/mL of Zinc Sulfate or 15 mg/mL 
of Zinc Sulfate.  See Table C within APPENDIX A of this document for details. 
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Single 
Analyte 
Initial Working Stock 
Solution #1 
(1 µg/mL) 
Total Volume= 10mL 
Working Stock 
Solutions #2 
(500 ng/mL) 
0.05% Ethanol Level 
Total Volume= 10mL 
Final Result 
Ethyl 
Glucuronide 
1 mg of 
EtG in 1 
mL or 
SurineTM 
 
10 µL of 1 mg/mL in 
9990 µL of SurineTM 
5 mL of 1 µg/mL 
Working Stock Sol. 
#1 in 500 µL of 
ethanol and 4.5 mL 
of SurineTM. 
3 mL of 500 
ng/mL Working 
Solution #2 was 
pipetted into 3 
glass vials, 
labeled Vials 4-
6.* 
 
* Vials 4, 5, and 6 contain either 0 mg/mL of Zinc Sulfate, 10 mg/mL of Zinc Sulfate or 15 mg/mL 
of Zinc Sulfate.  See Table C within APPENDIX A of this document for details. 
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Table B: Serial Dilutions for Obtaining 700 ng/mLEthyl Glucuronide. 
Single 
Analyte 
Initial Working Stock 
Solution #1 
(1 µg/mL) 
Total Volume=10mL  
Working Stock 
Solutions #2 
(700 ng/mL) 
0% Ethanol Level 
Total Volume = 10mL 
Final Result 
Ethyl 
Glucuronide 
1 mg of 
EtG in 1 
mL or 
SurineTM 
 
10 µL of 1 mg/mL in 
9990 µL of SurineTM 
7 mL of 1 µg/mL 
Working Stock Sol. 
#1 in 3 mL of 
SurineTM. 
3 mL of 500 
ng/mL Working 
Solution #2 was 
pipetted into 3 
glass vials, 
labeled Vials 7-
9.* 
 
* Vials 7, 8, and 9 contain either 0 mg/mL of Zinc Sulfate, 10 mg/mL of Zinc Sulfate or 15 
mg/mL of Zinc Sulfate.  See Table C within APPENDIX A of this document for details.. 
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Single 
Analyte 
Initial Working Stock 
Solution #1 
(1 µg/mL) 
Total Volume=10mL  
Working Stock 
Solutions #2 
(700 ng/mL) 
0.05% Ethanol Level 
Total Volume = 10mL 
Final Result 
Ethyl 
Glucuronide 
1 mg of 
EtG in 1 
mL or 
SurineTM 
 
10 µL of 1 mg/mL in 
9990 µL of SurineTM 
7 mL of 1 µg/mL 
Working Stock Sol. 
#1 in 500 µL of 
ethanol and 2.5 mL of 
SurineTM. 
3 mL of 500 
ng/mL Working 
Solution #2 was 
pipetted into 3 
glass vials, 
labeled  Vials 
10-12.* 
 
 
 
*Vials 10, 11, and 12 contain either 0 mg/mL of Zinc Sulfate, 10 mg/mL of Zinc Sulfate or 15 
mg/mL of Zinc Sulfate.  See Table C within APPENDIX A of this document for details. 
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Table C: Zinc Sulfate Measurements Using a Denver Instruments Pinnacle Balance 
 
Sample Vials Target Zinc Sulfate 
Level 
Actual Zinc Sulfate 
Level 
Vial 1  
(Total Volume= 3mL) 
0 mg/mL 0 mg/mL 
Vial 2  
(Total Volume= 3mL) 
10 mg/mL 
=30.0mg Total 
30.1 mg 
Vial 3  
(Total Volume= 3mL)  
15mg/mL 
=45.0 mg/mL Total 
44.9 mg 
Vial 4 
(Total Volume= 3mL) 
0 mg/mL 0 mg/mL 
Vial 5  
(Total Volume= 3mL) 
10 mg/mL 
=30.0mg/mL Total 
30.1 mg 
Vial 6  
(Total Volume= 3mL) 
15mg/mL 
=45.0 mg/mL Total 
45.0 mg 
Vial 7  
(Total Volume= 3mL) 
0 mg/mL 0 mg/mL 
Vial 8  
(Total Volume= 3mL) 
10 mg/mL 
=30.0mg/mL Total 
30.0 mg 
Vial 9  
(Total Volume= 3mL) 
15mg/mL 
=45.0 mg/mL Total 
45.1 mg 
Vial 10 
(Total Volume= 3mL) 
0 mg/mL 0 mg/mL 
Vial 11  
(Total Volume= 3mL) 
10 mg/mL 
=30.0mg/mL Total 
30.1 mg 
Vial 12  
(Total Volume= 3mL) 
15mg/mL 
=45.0 mg/mL Total 
45.1 mg 
Vial 13  
(Control/Just Urine) 
0 mg/mL 0 mg/mL 
Vial 14 
(Negative/No EtG Analyte) 
10 mg/mL 
=30.0mg/mL Total 
30.0 mg 
Vial 15 
(Negative/No EtG Analyte) 
15mg/mL 
=45.0 mg/mL Total 
45.0 mg 
Vial 16 
(Control/ Urine + Ethanol) 
0 mg/mL 0 mg/mL 
Vial 17 
(Negative/No EtG Analyte) 
10 mg/mL 
=30.0mg/mL Total 
30.3 mg 
Vial 18 
(Negative/No EtG Analyte) 
15mg/mL 
=45.0 mg/mL Total 
44.9 mg 
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Table D: Table Representation of Final Results with the EtG Immunoassay Tests from 
Drug Test In Bulk. 
 
Vial Ethanol 
% 
EtG 
Level 
Zinc Sulfate 
Level 
Duration Results with Drug Test 
In Bulk EtG Test 
1 0.00 % 500ng/mL 0 mg/mL Fresh 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
1 0.00 % 500ng/mL 0 mg/mL I Week 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
2 0.00 % 500ng/mL 10mg/mL Fresh 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
2 0.00 % 500ng/mL 10mg/mL I Week 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
3 0.00 % 500ng/mL 15 mg/mL Fresh 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
3 0.00 % 500ng/mL 15 mg/mL I Week 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
4 0.05% 500ng/mL 0 Fresh 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
4 0.05% 500ng/mL 0 I Week 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
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Vial Ethanol 
% 
EtG 
Level 
Zinc Sulfate 
Level 
Duration Results with Drug Test 
In Bulk EtG Test 
5 0.05% 500ng/mL 10 mg/mL Fresh 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
5 0.05% 500ng/mL 10 mg/mL I Week 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
6 0.05% 500ng/mL 15 mg/mL Fresh 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
6 0.05% 500ng/mL 15 mg/mL I Week 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
7 0.00% 700 
ng/mL 
0 Fresh 
 
Run 1 of 3: Positive  
 
Run 2 of 3: Positive 
 
Run 3 of 3: Positive 
7 0.00% 700 
ng/mL 
0 I Week 
 
Run 1 of 3: Positive  
 
Run 2 of 3: Positive 
 
Run 3 of 3: Positive 
8 0.00% 700 
ng/mL 
10mg/mL Fresh 
 
Run 1 of 3: Positive  
 
Run 2 of 3: Positive 
 
Run 3 of 3: Positive 
8 0.00% 700 
ng/mL 
10mg/mL I Week 
 
Run 1 of 3: Positive  
 
Run 2 of 3: Positive 
 
Run 3 of 3: Positive 
9 0.00% 700 
ng/mL 
15 mg/mL Fresh 
 
Run 1 of 3: Positive  
 
Run 2 of 3: Positive 
 
Run 3 of 3: Positive 
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Vial Ethanol 
% 
EtG 
Level 
Zinc Sulfate 
Level 
Duration Results with Drug Test 
In Bulk EtG Test 
9 0.00% 700 
ng/mL 
15 mg/mL I Week 
 
Run 1 of 3: Positive  
 
Run 2 of 3: Positive 
 
Run 3 of 3: Positive 
10 0.05%  700 
ng/mL 
0 Fresh 
 
Run 1 of 3: Positive  
 
Run 2 of 3: Positive 
 
Run 3 of 3: Positive 
10 0.05%  700 
ng/mL 
0 I Week 
 
Run 1 of 3: Positive  
 
Run 2 of 3: Positive 
 
Run 3 of 3: Positive 
11 0.05%  700 
ng/mL 
10 mg/mL Fresh 
 
Run 1 of 3: Positive  
 
Run 2 of 3: Positive 
 
Run 3 of 3: Positive 
11 0.05%  700 
ng/mL 
10 mg/mL I Week 
 
Run 1 of 3: Positive  
 
Run 2 of 3: Positive 
 
Run 3 of 3: Positive 
12 0.05%  700 
ng/mL 
15 mg/mL Fresh 
 
Run 1 of 3: Positive  
 
Run 2 of 3: Positive 
 
Run 3 of 3: Positive 
12 0.05%  700 
ng/mL 
15 mg/mL I Week 
 
Run 1 of 3: Positive  
 
Run 2 of 3: Positive 
 
Run 3 of 3: Positive 
13 0.00% 0 ng/mL 0 Fresh 
 
Run 1 of 3: Negative 
 
Run 2 of 3:Negative 
 
Run 3 of 3:Negative 
13 0.00% 0 ng/mL 0 I Week 
 
Run 1 of 3: Negative 
 
Run 2 of 3:Negative 
 
Run 3 of 3:Negative 
47 
Vial Ethanol 
% 
EtG 
Level 
Zinc Sulfate 
Level 
Duration Results with Drug Test 
In Bulk EtG Test 
14 0.00% 0 ng/mL 10 mg/mL Fresh 
 
Run 1 of 3: Negative 
 
Run 2 of 3:Negative 
 
Run 3 of 3:Negative 
14 0.00% 0 ng/mL 10 mg/mL I Week 
 
Run 1 of 3: Negative 
 
Run 2 of 3:Negative 
 
Run 3 of 3:Negative 
15 0.00% 0 ng/mL 15 mg/mL Fresh 
 
Run 1 of 3: Negative 
 
Run 2 of 3:Negative 
 
Run 3 of 3:Negative 
15 0.00% 0 ng/mL 15 mg/mL I Week 
 
Run 1 of 3: Negative 
 
Run 2 of 3:Negative 
 
Run 3 of 3:Negative 
16 0.05%  0 ng/mL 0 Fresh 
 
Run 1 of 3: Negative 
 
Run 2 of 3:Negative 
 
Run 3 of 3:Negative 
16 0.05%  0 ng/mL 0 I Week 
 
Run 1 of 3: Negative 
 
Run 2 of 3:Negative 
 
Run 3 of 3:Negative 
17 0.05%  0 ng/mL 10 mg/mL Fresh 
 
Run 1 of 3: Negative 
 
Run 2 of 3:Negative 
 
Run 3 of 3:Negative 
17 0.05%  0 ng/mL 10 mg/mL I Week 
 
Run 1 of 3: Negative 
 
Run 2 of 3:Negative 
 
Run 3 of 3:Negative 
18 0.05%  0 ng/mL 15 mg/mL Fresh 
 
Run 1 of 3: Negative 
 
Run 2 of 3:Negative 
 
Run 3 of 3:Negative 
48 
Vial Ethanol 
% 
EtG 
Level 
Zinc Sulfate 
Level 
Duration Results with Drug Test 
In Bulk EtG Test 
18 0.05%  0 ng/mL 15 mg/mL I Week 
 
Run 1 of 3: Negative 
 
Run 2 of 3:Negative 
 
Run 3 of 3:Negative 
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Table E: Table Representation of Final Results with the EtG Immunoassay Tests from 
TransMed Drug Testing and Laboratories. 
 
Vial Ethanol 
% 
EtG 
Level 
Zinc Sulfate 
Level 
Duration Results with TransMed 
EtG Tests 
1 0.00 % 500ng/mL 0 mg/mL Fresh 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
1 0.00 % 500ng/mL 0 mg/mL I Week 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
2 0.00 % 500ng/mL 10mg/mL Fresh 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
2 0.00 % 500ng/mL 10mg/mL I Week 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
3 0.00 % 500ng/mL 15 mg/mL Fresh 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
3 0.00 % 500ng/mL 15 mg/mL I Week 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
4 0.05% 500ng/mL 0 Fresh 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
4 0.05% 500ng/mL 0 I Week 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
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Vial Ethanol 
% 
EtG 
Level 
Zinc Sulfate 
Level 
Duration Results with TransMed 
EtG Tests 
5 0.05% 500ng/mL 10 mg/mL Fresh 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
5 0.05% 500ng/mL 10 mg/mL I Week 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
6 0.05% 500ng/mL 15 mg/mL Fresh 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
6 0.05% 500ng/mL 15 mg/mL I Week 
 
Run 1 of 3: Invalid  
 
Run 2 of 3: Invalid 
 
Run 3 of 3: Invalid 
7 0.00% 700 
ng/mL 
0 Fresh 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
7 0.00% 700 
ng/mL 
0 I Week 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
8 0.00% 700 
ng/mL 
10mg/mL Fresh 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
8 0.00% 700 
ng/mL 
10mg/mL I Week 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
9 0.00% 700 
ng/mL 
15 mg/mL Fresh 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
51 
Vial Ethanol 
% 
EtG 
Level 
Zinc Sulfate 
Level 
Duration Results with TransMed 
EtG Tests 
9 0.00% 700 
ng/mL 
15 mg/mL I Week 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
10 0.05%  700 
ng/mL 
0 Fresh 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
10 0.05%  700 
ng/mL 
0 I Week 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
11 0.05%  700 
ng/mL 
10 mg/mL Fresh 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
11 0.05%  700 
ng/mL 
10 mg/mL I Week 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
12 0.05%  700 
ng/mL 
15 mg/mL Fresh 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
12 0.05%  700 
ng/mL 
15 mg/mL I Week 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
13 0.00% 0 ng/mL 0 Fresh 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
13 0.00% 0 ng/mL 0 I Week 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
52 
Vial Ethanol 
% 
EtG 
Level 
Zinc Sulfate 
Level 
Duration Results with TransMed 
EtG Tests 
14 0.00% 0 ng/mL 10 mg/mL Fresh 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
14 0.00% 0 ng/mL 10 mg/mL I Week 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
15 0.00% 0 ng/mL 15 mg/mL Fresh 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
15 0.00% 0 ng/mL 15 mg/mL I Week 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
16 0.05%  0 ng/mL 0 Fresh 
 
Run 1 of 3: Negative 
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
16 0.05%  0 ng/mL 0 I Week 
 
Run 1 of 3: Negative 
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
17 0.05%  0 ng/mL 10 mg/mL Fresh 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
17 0.05%  0 ng/mL 10 mg/mL I Week 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
18 0.05%  0 ng/mL 15 mg/mL Fresh 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
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Vial Ethanol 
% 
EtG 
Level 
Zinc Sulfate 
Level 
Duration Results with TransMed 
EtG Tests 
18 0.05%  0 ng/mL 15 mg/mL I Week 
 
Run 1 of 3: Negative  
 
Run 2 of 3: Negative 
 
Run 3 of 3: Negative 
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